|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 39072 |
FusionGeneSummary for TOMM7_NCBP1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: TOMM7_NCBP1 | Fusion gene ID: 39072 | Hgene | Tgene | Gene symbol | TOMM7 | NCBP1 | Gene ID | 54543 | 4686 |
| Gene name | translocase of outer mitochondrial membrane 7 | nuclear cap binding protein subunit 1 | |
| Synonyms | TOM7 | CBP80|NCBP|Sto1 | |
| Cytomap | 7p15.3 | 9q22.33 | |
| Type of gene | protein-coding | protein-coding | |
| Description | mitochondrial import receptor subunit TOM7 homolog6.2 kd proteintranslocase of outer membrane 7 kDa subunit homologtranslocase of outer mitochondrial membrane 7 homolog | nuclear cap-binding protein subunit 180 kDa nuclear cap-binding proteinNCBP 80 kDa subunitnuclear cap binding protein subunit 1, 80kDa | |
| Modification date | 20180522 | 20180523 | |
| UniProtAcc | Q9P0U1 | Q09161 | |
| Ensembl transtripts involved in fusion gene | ENST00000463284, ENST00000358435, ENST00000405021, ENST00000372879, | ENST00000375147, ENST00000491445, | |
| Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 4 X 4 X 3=48 |
| # samples | 3 | 4 | |
| ** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: TOMM7 [Title/Abstract] AND NCBP1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | NCBP1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 11551508|17873884 |
| Tgene | NCBP1 | GO:0006370 | 7-methylguanosine mRNA capping | 12434151 |
| Tgene | NCBP1 | GO:0006446 | regulation of translational initiation | 11551508 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | AW877449 | TOMM7 | chr7 | 22852892 | + | NCBP1 | chr9 | 100435853 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000463284 | ENST00000375147 | TOMM7 | chr7 | 22852892 | + | NCBP1 | chr9 | 100435853 | - |
| intron-3UTR | ENST00000463284 | ENST00000491445 | TOMM7 | chr7 | 22852892 | + | NCBP1 | chr9 | 100435853 | - |
| intron-3UTR | ENST00000358435 | ENST00000375147 | TOMM7 | chr7 | 22852892 | + | NCBP1 | chr9 | 100435853 | - |
| intron-3UTR | ENST00000358435 | ENST00000491445 | TOMM7 | chr7 | 22852892 | + | NCBP1 | chr9 | 100435853 | - |
| intron-3UTR | ENST00000405021 | ENST00000375147 | TOMM7 | chr7 | 22852892 | + | NCBP1 | chr9 | 100435853 | - |
| intron-3UTR | ENST00000405021 | ENST00000491445 | TOMM7 | chr7 | 22852892 | + | NCBP1 | chr9 | 100435853 | - |
| intron-3UTR | ENST00000372879 | ENST00000375147 | TOMM7 | chr7 | 22852892 | + | NCBP1 | chr9 | 100435853 | - |
| intron-3UTR | ENST00000372879 | ENST00000491445 | TOMM7 | chr7 | 22852892 | + | NCBP1 | chr9 | 100435853 | - |
Top |
FusionProtFeatures for TOMM7_NCBP1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| TOMM7 | NCBP1 |
| Required for assembly and stability of the TOM complex.Positive regulator of PRKN translocation to damaged mitochondria.Acts probably by stabilizing PINK1 on the outer membrane ofdepolarized mitochondria. {ECO:0000269|PubMed:18331822,ECO:0000269|PubMed:24270810}. | Component of the cap-binding complex (CBC), which bindscotranscriptionally to the 5'-cap of pre-mRNAs and is involved invarious processes such as pre-mRNA splicing, translationregulation, nonsense-mediated mRNA decay, RNA-mediated genesilencing (RNAi) by microRNAs (miRNAs) and mRNA export. The CBCcomplex is involved in mRNA export from the nucleus via itsinteraction with ALYREF/THOC4/ALY, leading to the recruitment ofthe mRNA export machinery to the 5'-end of mRNA and to mRNA exportin a 5' to 3' direction through the nuclear pore. The CBC complexis also involved in mediating U snRNA and intronless mRNAs exportfrom the nucleus. The CBC complex is essential for a pioneer roundof mRNA translation, before steady state translation when the CBCcomplex is replaced by cytoplasmic cap-binding protein eIF4E. Thepioneer round of mRNA translation mediated by the CBC complexplays a central role in nonsense-mediated mRNA decay (NMD), NMDonly taking place in mRNAs bound to the CBC complex, but not oneIF4E-bound mRNAs. The CBC complex enhances NMD in mRNAscontaining at least one exon-junction complex (EJC) via itsinteraction with UPF1, promoting the interaction between UPF1 andUPF2. The CBC complex is also involved in 'failsafe' NMD, which isindependent of the EJC complex, while it does not participate inStaufen-mediated mRNA decay (SMD). During cell proliferation, theCBC complex is also involved in microRNAs (miRNAs) biogenesis viaits interaction with SRRT/ARS2 and is required for miRNA-mediatedRNA interference. The CBC complex also acts as a negativeregulator of PARN, thereby acting as an inhibitor of mRNAdeadenylation. In the CBC complex, NCBP1/CBP80 does not binddirectly capped RNAs (m7GpppG-capped RNA) but is required tostabilize the movement of the N-terminal loop of NCBP2/CBP20 andlock the CBC into a high affinity cap-binding state with the capstructure. Associates with NCBP3 to form an alternative cap-binding complex (CBC) which plays a key role in mRNA export and isparticularly important in cellular stress situations such as virusinfections. The conventional CBC with NCBP2 binds both smallnuclear RNA (snRNA) and messenger (mRNA) and is involved in theirexport from the nucleus whereas the alternative CBC with NCBP3does not bind snRNA and associates only with mRNA thereby playinga role only in mRNA export. NCBP1/CBP80 is required for cellgrowth and viability (PubMed:26382858).{ECO:0000269|PubMed:11551508, ECO:0000269|PubMed:12093754,ECO:0000269|PubMed:15059963, ECO:0000269|PubMed:15361857,ECO:0000269|PubMed:16186820, ECO:0000269|PubMed:16317009,ECO:0000269|PubMed:17190602, ECO:0000269|PubMed:17873884,ECO:0000269|PubMed:18369367, ECO:0000269|PubMed:19632182,ECO:0000269|PubMed:19648179, ECO:0000269|PubMed:26382858,ECO:0000269|PubMed:7651522, ECO:0000269|PubMed:8069914}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TOMM7_NCBP1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TOMM7_NCBP1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TOMM7_NCBP1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TOMM7_NCBP1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|